Disease Pathway Cut for Multi-Target drugs
Abstract Background Biomarker discovery studies have been moving the focus from a single target gene to a set of target genes. However, the number of target genes in a drug should be minimum to avoid drug side-effect or toxicity. But still, the set of target genes should effectively block all possib...
Main Authors: | Sunjoo Bang, Sangjoon Son, Sooyoung Kim, Hyunjung Shin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-02-01
|
Series: | BMC Bioinformatics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12859-019-2638-3 |
Similar Items
-
The identification of key genes and pathways in glioblastoma by bioinformatics analysis
by: Zahra Farsi, et al.
Published: (2023-12-01) -
Identification of cluster of proteins in the network of MAPK pathways as cancer drug targets
by: V.K. MD Aksam, et al.
Published: (2017-01-01) -
Mechanisms of Natural Extracts of <i>Andrographis paniculata</i> That Target Lipid-Dependent Cancer Pathways: A View from the Signaling Pathway
by: Ruth Naomi, et al.
Published: (2022-05-01) -
Insights into molecular pathways for targeted therapeutics in acute leukaemia
by: V Stavropoulou, et al.
Published: (2010-08-01) -
Gene Expression Profiling in Fibromyalgia Indicates an Autoimmune Origin of the Disease and Opens New Avenues for Targeted Therapy
by: Marzia Dolcino, et al.
Published: (2020-06-01)